All In Biotech

Drug Trial Radar · NCT02051790

Evaluation of Reader Training Processes

Evaluation of Reader Training Processes by Comparing Clinical Interpretations to Centralized Expert Reads

Last checked: Nov 19, 2026Latest source record: Sep 28, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

241

Actual

Start

Mar 2014

Primary completion

Aug 2014

Study completion Aug 2014

Sponsor

Lead sponsor
Avid RadiopharmaceuticalsIndustry
Sponsor type
Industry
First posted
Jan 31, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Single group
Masking
Single (outcomes assessor)
Primary purpose
Diagnostic
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is designed to evaluate the agreement between florbetapir F 18 scan interpretation in the clinic and by expert readers.

Conditions

  • Alzheimer's Disease

Interventions

  • florbetapir F 18Drug

    No study drug will be administered in this study - scans previously acquired in the course of clinical practice.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Agreement Between Expert Panel and Clinical Practice ReadsTime frame: Scan acquired 50-60 minutes post injection

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Research Site

    Philadelphia, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.